Offerings // Bioventus Inc.

BVS offering history

Every offering-related filing in Bioventus Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 460 filings back to Apr 19, 2016.

Last executed offering

Feb 17, 2021

8-K — priced deal (shares or notes)

Last registration (announced)

Oct 25, 2024

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Nov 4, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 4, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 25, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Sep 24, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 24, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 17, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 12, 2021	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Feb 10, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Feb 10, 2021	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Feb 10, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 4, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 20, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Aug 2, 2016	RW →	WITHDRAWN	Registration withdrawn
Jul 27, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jul 25, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jul 19, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 30, 2016	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

BVS offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BVS workspace →

BVS offering FAQ

When did BVS last execute an offering?

Per SEC filings, Bioventus Inc.'s most recent priced offering document is a 8-K filed 2021-02-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BVS last announce or register an offering?

The most recent registration is a S-3 filed 2024-10-25. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.